Literature DB >> 2162811

Distribution of progestin-binding cells in estrogen-treated and untreated neonatal mouse uterus and oviduct: autoradiographic study with [125I]progestin.

R Murakami1, P J Shughrue, W E Stumpf, W Elger, P E Schulze.   

Abstract

Progestin-binding sites in uteri and oviducts of estrogen-treated and untreated 8-day-old mice were studied by thaw-mount autoradiography with [125I]progestin. In the untreated uteri, nuclear concentration of radiolabelled progestin was observed in all tissues of the uterus, with strongest nuclear labelling in luminal and glandular epithelia and in stroma. In the estrogen-treated uteri, the degree of labelling was markedly augmented in stroma and muscle, but much reduced in the luminal and glandular epithelia, compared to untreated uteri. In untreated oviducts, nuclear labelling was observed in stroma and muscle in all regions and in epithelium in the isthmic and uterine regions. The epithelium in infundibular and ampullar regions was only scarcely labelled. The estrogen-treatment augmented the labelling in stroma and muscle of the oviduct as in the uterus, but the labelling in epithelium was not affected. These results indicate that estrogen-treatment induces progesterone receptor differentially among tissue compartments both in the uterus and oviduct.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162811     DOI: 10.1007/BF02440182

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  14 in total

1.  Immunodetection of estrogen receptor in epithelial and stromal tissues of neonatal mouse uterus.

Authors:  K S Korach; T Horigome; Y Tomooka; S Yamashita; R R Newbold; J A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 2.  Cytological basis for permanent vaginal changes in mice treated neonatally with steroid hormones.

Authors:  N Takasugi
Journal:  Int Rev Cytol       Date:  1976

3.  Regulation of progesterone receptor formation by estrogen action.

Authors:  W W Leavitt; T J Chen; T C Allen
Journal:  Ann N Y Acad Sci       Date:  1977-03-11       Impact factor: 5.691

4.  Estrogen receptors in the fetal mouse.

Authors:  W E Stumpf; R Narbaitz; M Sar
Journal:  J Steroid Biochem       Date:  1980-01       Impact factor: 4.292

5.  Autoradiographic analysis of nuclear estrogen binding sites during postnatal development of the genital tract of female mice.

Authors:  G R Cunha; J M Shannon; K D Vanderslice; M Sekkingstad; S J Robboy
Journal:  J Steroid Biochem       Date:  1982-09       Impact factor: 4.292

6.  Progesterone receptors in the fetal uterus and ovary of the guinea pig: evolution during fetal development and induction and stimulation in estradiol-primed animals.

Authors:  J R Pasqualini; B L Nguyen
Journal:  Endocrinology       Date:  1980-04       Impact factor: 4.736

7.  Autoradiographic studies on the fetal and newborn uteri of the guinea pig after injection of 3H-progesterone into non-treated and into estradiol-primed animals.

Authors:  J Tardy; J R Pasqualini
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

8.  The distribution of progesterone receptor in the 20-day-old fetal mouse: an autoradiographic study with [125I]progestin.

Authors:  P J Shughrue; W E Stumpf; M Sar
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

9.  Differential induction of progestin-binding sites in uterine cell types by estrogen and antiestrogen.

Authors:  B W Ennis; W E Stumpf
Journal:  Endocrinology       Date:  1988-10       Impact factor: 4.736

10.  Prenatal diethylstilbestrol exposure alters murine uterine responses to prepubertal estrogen stimulation.

Authors:  D B Maier; R R Newbold; J A McLachlan
Journal:  Endocrinology       Date:  1985-05       Impact factor: 4.736

View more
  1 in total

1.  Progesterone as a morphological regulatory factor of the male and female gerbil prostate.

Authors:  Ricardo A Fochi; Fernanda C A Santos; Rejane M Goes; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2013-12       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.